
Picture Health develops multimodal AI-powered biomarkers and collaborates with academic institutions and biopharma to drive innovation in oncology and enable optimal treatment selection for patients. Their Px platform transforms radiology and pathology images into actionable insights by quantifying novel biological properties of tumors and their surroundings. These interpretable biomarkers can characterize patients better, enhance patient selection, and improve clinical trial results for biopharma and researchers, while optimizing treatment strategies for clinicians. The Px AI is rooted in biology, multimodal (integrating radiology, pathology, genomic, and clinical data), and requires only routine data, providing insights in minutes without additional tissue or lab tests. It leverages a proprietary Feature Library to build customizable biomarkers quickly, even without large datasets, enabling better and earlier response prediction and improved patient characterization.

Picture Health develops multimodal AI-powered biomarkers and collaborates with academic institutions and biopharma to drive innovation in oncology and enable optimal treatment selection for patients. Their Px platform transforms radiology and pathology images into actionable insights by quantifying novel biological properties of tumors and their surroundings. These interpretable biomarkers can characterize patients better, enhance patient selection, and improve clinical trial results for biopharma and researchers, while optimizing treatment strategies for clinicians. The Px AI is rooted in biology, multimodal (integrating radiology, pathology, genomic, and clinical data), and requires only routine data, providing insights in minutes without additional tissue or lab tests. It leverages a proprietary Feature Library to build customizable biomarkers quickly, even without large datasets, enabling better and earlier response prediction and improved patient characterization.
Founded: 2021
Headquarters: Cleveland, Ohio, United States
Product: Px platform — multimodal AI imaging biomarkers for oncology
Tech: Integrates radiology, pathology, genomic, and clinical data
Recent support: Non-equity assistance reported Jul 2, 2024 (PharmStars)
Oncology diagnostics, patient stratification, and clinical trial enrichment
2021
Biotechnology
Reported non-equity assistance round
“PharmStars listed as a disclosed supporter via non-equity assistance reported July 2, 2024.”